OptimizeRx (OPRX) PT Raised to $2.50 at Lake Street Capital
OptimizeRx (OTCMKTS:OPRX) had its target price lifted by Lake Street Capital to $2.50 in a research report released on Wednesday morning, The Fly reports. They currently have a buy rating on the technology company’s stock.
Shares of OptimizeRx (OTCMKTS:OPRX) opened at $1.55 on Wednesday. OptimizeRx has a 1 year low of $0.63 and a 1 year high of $1.66. The stock has a market cap of $45.38, a price-to-earnings ratio of -22.14 and a beta of 0.77.
OptimizeRx Company Profile
Receive News & Ratings for OptimizeRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OptimizeRx and related companies with MarketBeat.com's FREE daily email newsletter.